Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts

Hypothyroidism and thyrotoxicosis are each associated with an increased risk of fracture. Although thyroxine (T4) is the predominant circulating thyroid hormone, target cell responses are determined by local intracellular availability of the active hormone 3,5,3′-L-triiodothyronine (T3), which is generated from T4 by the type 2 deiodinase enzyme (D2). To investigate the role of locally produced T3 in bone, we characterized mice deficient in D2 (D2KO) in which the serum T3 level is normal. Bones from adult D2KO mice have reduced toughness and are brittle, displaying an increased susceptibility to fracture. This phenotype is characterized by a 50% reduction in bone formation and a generalized increase in skeletal mineralization resulting from a local deficiency of T3 in osteoblasts. These data reveal an essential role for D2 in osteoblasts in the optimization of bone strength and mineralization.

[1]  A. S. Clark,et al.  Life without thyroxine to 3,5,3'-triiodothyronine conversion: studies in mice devoid of the 5'-deiodinases. , 2009, Endocrinology.

[2]  J. Bassett,et al.  Critical role of the hypothalamic-pituitary-thyroid axis in bone. , 2008, Bone.

[3]  T. Visser,et al.  Iodothyronine deiodinase enzyme activities in bone , 2008, Bone.

[4]  S. Vukicevic,et al.  Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss , 2008, Proceedings of the National Academy of Sciences.

[5]  A. Boyde,et al.  Thyroid status during skeletal development determines adult bone structure and mineralization. , 2007, Molecular endocrinology.

[6]  A. S. Clark,et al.  Thyroid hormone homeostasis and action in the type 2 deiodinase-deficient rodent brain during development. , 2007, Endocrinology.

[7]  A. Boyde,et al.  Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. , 2007, Molecular endocrinology.

[8]  P. Larsen,et al.  Mice with impaired extrathyroidal thyroxine to 3,5,3'-triiodothyronine conversion maintain normal serum 3,5,3'-triiodothyronine concentrations. , 2007, Endocrinology.

[9]  A. Bianco,et al.  Deiodinases: implications of the local control of thyroid hormone action. , 2006, The Journal of clinical investigation.

[10]  S. Fiering,et al.  Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice. , 2006, Endocrinology.

[11]  Sheue-yann Cheng,et al.  Contrasting Skeletal Phenotypes in Mice with an Identical Mutation Targeted to Thyroid Hormone Receptor α1 or β , 2005 .

[12]  P. Vestergaard,et al.  Influence of Hyper- and Hypothyroidism, and the Effects of Treatment with Antithyroid Drugs and Levothyroxine on Fracture Risk , 2005, Calcified Tissue International.

[13]  C. Tabin,et al.  The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate , 2005, Nature Cell Biology.

[14]  森村 匡志.  Expression of type 2 iodothyronine deiodinase in human osteoblast is stimulated by thyrotropin , 2005 .

[15]  Sheue-yann Cheng,et al.  Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 or beta. , 2005, Molecular endocrinology.

[16]  J. Harney,et al.  Type 2 iodothyronine selenodeiodinase is expressed throughout the mouse skeleton and in the MC3T3-E1 mouse osteoblastic cell line during differentiation. , 2005, Endocrinology.

[17]  H. Schirmer,et al.  Self-reported diseases and the risk of non-vertebral fractures: the Tromsø study , 2005, Osteoporosis International.

[18]  E. Murphy,et al.  The thyroid and the skeleton , 2004, Clinical endocrinology.

[19]  R. Goodyear,et al.  Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Zaidi,et al.  TSH Is a Negative Regulator of Skeletal Remodeling , 2003, Cell.

[21]  Sheue-yann Cheng,et al.  A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone. , 2003, Molecular endocrinology.

[22]  P. Vestergaard,et al.  Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. , 2002, Thyroid : official journal of the American Thyroid Association.

[23]  S. Fiering,et al.  Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. , 2001, Molecular endocrinology.

[24]  M. Itoman,et al.  Thyroid hormone-induced chondrocyte terminal differentiation in rat femur organ culture , 1998, Cell and Tissue Research.

[25]  J. Köhrle,et al.  Selenoproteins are expressed in fetal human osteoblast-like cells. , 1998, Biochemical and biophysical research communications.

[26]  A. Reddi,et al.  Thyroxine is the serum factor that regulates morphogenesis of columnar cartilage from isolated chondrocytes in chemically defined medium , 1994, The Journal of cell biology.

[27]  M. Berry,et al.  Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5' deiodinase deficiency. , 1993, The Journal of clinical investigation.

[28]  T. Visser,et al.  Impairment of the selenoenzyme type I iodothyronine deiodinase in C3H/He mice. , 1993, Endocrinology.

[29]  T. Tschan,et al.  Induction of proliferation or hypertrophy of chondrocytes in serum-free culture: the role of insulin-like growth factor-I, insulin, or thyroxine , 1992, The Journal of cell biology.

[30]  L. Mosekilde,et al.  Effects of thyroid hormones on bone and mineral metabolism. , 1990, Endocrinology and metabolism clinics of North America.

[31]  J. Hershman,et al.  Thyroid hormone 5′‐deiodinase activity, nuclear binding, and effects on mitogenesis in umr‐106 osteoblastic osteosarcoma cells , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  F. Melsen,et al.  Kinetics of trabecular bone resorption and formation in hypothyroidism: evidence for a positive balance per remodeling cycle. , 1986, Bone.

[33]  L. Mosekilde,et al.  TRABECULAR BONE MINERALIZATION LAG TIME DETERMINED BY TETRACYCLINE DOUBLE‐LABELING IN NORMAL AND CERTAIN PATHOLOGICAL CONDITIONS , 1980, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[34]  L. Mosekilde,et al.  Morphometric and Dynamic Studies of Bone Changes in Hypothyroidism , 1978, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.